Back to trial details

Intake questionnaire

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

Applying to Sarah Cannon and HCA Research Institute · Nashville, Tennessee

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Epidermal Growth Factor?
3. Are you able to travel to Nashville for study visits?